在帕金森病中α-synuclein的聚合和相分离
Wanlu Han1, Mengrui Wei1, Fei Xu1
1School of Pharmacy, Henan University, Kaifeng, Henan 475004, China. nz@henu.edu.cn.
概括
帕金森病涉及α-synuclein (α-Syn) 聚合和病理阶段过渡. 了解这些过程,包括液-液相分离 (LLPS) 和液-固相过渡 (LSPT),对于开发新的帕金森病疗法至关重要.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 病理学 病理学 病理学
背景情况:
- 将α-synuclein (α-Syn) 聚合到Lewy体中是帕金森病 (PD) 的一个关键标志.
- α-Syn聚合涉及核和延长步骤,导致结构多态.
- 液态-液态相分离 (LLPS) 和随后的液态-固态相转换 (LSPT) 都与α-Syn粉样沉积有关.
研究的目的:
- 要总结目前对PD中的α-Syn聚合机制的理解.
- 探索LLPS和异常LSPT在α-Syn病变发生中的作用.
- 调查蛋白质聚合,结构多态和PD进展之间的相关性.
主要方法:
- 关于α-Syn聚合和相分离的现有文献的综述.
- 对α-Syn纤维化的核和延长模型的分析.
- 讨论异型交叉粉样蛋白相互作用及其影响.
主要成果:
- α-Syn聚合通过核和延长而进展,形成粉样沉积物.
- α-Syn的LLPS可以通过异常的LSPT成熟为固体聚合物.
- 异常的LSPT有助于PD的发病和发展.
结论:
- 了解α-Syn聚合,LLPS和LSPT对于PD病变发生至关重要.
- 在α-Syn聚合中异常的相位过渡为PD提供了潜在的治疗点.
- 对这些机制的进一步研究可能会导致对帕金森病的新型干预措施.
更多相关视频
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
10.6K
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
10.7K
相关概念视频
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Parkinson's Disease: Overview
528
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
528
